Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
TwinStrand Biosciences, Inc. holds a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company currently has 2 pending office actions, both of which are located within 1 distinct art unit. This concentration suggests that while the company has multiple active applications, they are all being evaluated within the same technical specialty at the patent office. This allows the legal team to focus on the specific trends and precedents relevant to this 1 distinct art unit.
The examination of these applications is split between 2 distinct examiners. GRAY, JESSICA is identified as the busiest examiner for the portfolio, currently managing 1 pending office action. Since there are 2 pending office actions and 2 distinct examiners, the company receives feedback from multiple individuals within the same 1 distinct art unit. Practitioners can use this to compare how different examiners handle the company's biotechnology and pharmaceutical claims. The relationship with GRAY, JESSICA is a key component of this dual-examiner strategy within the centralized art unit environment, providing a broader view of the unit's internal logic.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRAY, JESSICA | 1 | 0.0% | +0.0% |
| HANEY, AMANDA MARIE | 1 | 36.4% | +44.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18347413 | REAGENTS AND ADAPTERS FOR NUCLEIC ACID SEQUENCING AND METHODS FOR MAKING SUCH REAGENTS AND ADAPTERS | GRAY, JESSICA | — |
| 16969531 | METHODS AND REAGENTS FOR DETECTING AND ASSESSING GENOTOXICITY | HANEY, AMANDA MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16969531 | METHODS AND REAGENTS FOR DETECTING AND ASSESSING GENOTOXICITY | HANEY, AMANDA MARIE | — |
| Art Unit | Apps |
|---|---|
| 1682 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18347413 | REAGENTS AND ADAPTERS FOR NUCLEIC ACID SEQUENCING AND METHODS FOR MAKING SUCH REAGENTS AND ADAPTERS | GRAY, JESSICA | 1682 | §103§112 | Non-Final OA | — | Pending | Jul 05, 2023 |
| 16969531 | METHODS AND REAGENTS FOR DETECTING AND ASSESSING GENOTOXICITY | HANEY, AMANDA MARIE | 1682 | §101§103 | Final Rejection | — | Pending | Dec 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial